Skip to content Skip to footer

International Cannabis Weekly: 337

February 16, 2024

Highlights

Share this story
Highlights

EU SIGNALS INCREASING SHIFT IN ATTITUDE TOWARDS CANNABIS REFORM

The European Commission (EC) last week partially approved a new ‘European Citizens Initiative’ focused on cannabis reform, in a move marking an increasing acknowledgment of the changing landscape in regards to cannabis regulation.

READ MORE  »

PRESIDENT ZELENSKY SIGNS BILL LEGALISING MEDICAL CANNABIS IN UKRAINE

READ MORE »

US CANNABIS FIRMS FACE NEW OWNERSHIP REPORTING RULE UNDER FEDERAL LAW

READ MORE »

Highlights

Share this story
Europe
  • Germany’s cannabis legalisation bill set for next week’s legislative agenda, April adoption plans remain on schedule.
  • Jersey officially decriminalised cannabis for personal use, reflecting evolving legal landscape and public sentiment.
  • Organigram sends first bulk cannabis shipment to Sanity Group’s medical division in Germany.
  • MGC Pharmaceuticals set to rebrand to Argent BioPharma in a bid to diversify after industry difficulties.
  • Irish Government approves establishment of a committee to examine drug decriminalisation ‘as quickly as possible’.
  • Glass Pharms completes construction of cultivation facility as it prepares to enter UK market.

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Webinar

Highlights

Share this story
Canada

Highlights

Share this story
New Data

Highlights

Share this story
LATAM & The Caribbean

Highlights

Share this story
APAC

Highlights

Share this story
Africa & The Middle East
Latest Issues

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.